Dagmar Meissner

Dagmar has 18 years of extensive experience in the biotech field, including cell based therapies, biopolymers, sustained drug delivery, mammalian cell recovery, recombinant protein isolation with strong skills in Process Optimization and Scale-up, Technology Transfer, and Project Management. Dagmar has directed process development activities at MicroIslet, Inc., Monsanto/CP Kelco (formerly Kelco Biopolymers), Pacira Pharmaceuticals (formerly DepoTech Corp), and Biogen Inc to support preclinical and clinical studies (Phase I-III). ). In 2009 she founded BioProcess Solutions LLC and has been working as an independent consultant. As a consultant she has worked on the Process Development of vaccine and protein products in Phase I-III and CMC support, including process optimization, process characterization, risk assessment, and process validation, as well as project management. She received her BS in chemical engineering from Fachhochschule für Technik Mannheim (PolyTechnic Institute) in Germany, and her MS in Chemical Engineering from Tufts University.